NASDAQ •
Healthcare •
Diagnostics & Research •
Quote as of 05/07/2026 16:00
Company Profile
IndustryDiagnostics & Research
SectorHealthcare
ExchangeNASDAQ
Market Capitalization3,916.45 mln
Float23.16 mln
Earnings Date05/06/2026
EPS
0.14
Overpriced
P / E
664
Bubble territory
1-Year Forecast
117
Strong upside
Relative Strength
88
/ 100
Strongly outperforming
Debt / Equity
0.23
Very low leverage
Pre-Tax Margin
11.12%
Moderate margin
Business Description
BillionToOne is a California-based diagnostics company founded in 2016 that uses advanced DNA measurement technology to improve how diseases are detected and monitored. Its products include a prenatal blood test that screens for genetic conditions in unborn babies, as well as cancer tests that identify tumor mutations and track how well a patient is responding to treatment. These cancer tests work without requiring a tissue sample, making them less invasive while still delivering highly accurate results.
